MAP2K2 and cancer: In order to identify new potential inhibitors from the pool of the natural compound known as flavonoids against the therapeutic cancer target MEK2, this study is primarily focused on computer-aided drug design approaches, such as virtual screening, ADMET prediction, molecular docking, and molecular dynamics simulations.